Glims Tablet

About Glims 3 mg Tablet

Glims 3 mg Tablet is a prescription tablet containing glimepiride, a sulfonylurea medicine used to lower blood glucose in adults with type II diabetes when diet and exercise alone are not enough. It is manufactured by Opsonin Pharma Limited.

There are 41 brands of Glimepiride listed in Bangladesh. 19 of them have a lower unit price than Glims. The lowest listed price is Mepid 1 mg Tablet at ৳ 2.51 per unit.

What is Glims 3 mg Tablet?

Glims 3 mg Tablet is an oral diabetes medicine whose active ingredient is glimepiride, belonging to the sulfonylurea group. It helps lower blood glucose in adults with type II (non-insulin dependent) diabetes whose blood sugar is not controlled by diet and exercise alone. It works mainly by stimulating the release of insulin from the pancreas. It may also be used together with metformin when diet, exercise and either medicine alone do not give adequate control. Glims is available in a 2 x 15 pack and must be used only under a doctor's supervision.

Uses of Glims

Glims 3 mg Tablet is used alongside diet and exercise to lower blood glucose in adults with type II diabetes whose hyperglycaemia is not controlled by diet and exercise alone. It may also be prescribed with metformin when diet, exercise and glimepiride or metformin alone do not give adequate control. It is not for type I diabetes, diabetic ketoacidosis or diabetic coma. Only a doctor can decide whether it suits a particular patient.

How to use Glims

Take Glims 3 mg Tablet exactly as your doctor tells you. The doctor decides the dose, how often it is taken and for how long, based on regular checks of glucose in your blood and urine. Do not change the dose yourself. Follow your diet and exercise plan as advised. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist rather than guessing.

Side effects of Glims

Low blood sugar (hypoglycaemia) is the main concern with Glims 3 mg Tablet and may be more likely in the first weeks of treatment, so careful monitoring is needed. Other side effects can include temporary visual problems, nausea, vomiting, diarrhoea, abdominal pain, urticaria and a fall in blood pressure. If you notice any of these, or symptoms of low blood sugar, contact your doctor promptly.

Safety and precautions

Glims 3 mg Tablet must not be used in type I diabetes, diabetic ketoacidosis or diabetic coma, or by people allergic to glimepiride, other sulfonylureas or other sulfonamides. It is also unsuitable for people with severe liver or kidney problems and for dialysis patients. It must not be taken during pregnancy or while breastfeeding; a changeover to insulin is needed, so tell your doctor if you are pregnant or planning a pregnancy. Ask your doctor first if you have other health problems or take other medicines.

Frequently asked questions

How much does Glims 3 mg Tablet cost?

The listed price is ৳ 7.74. Ask your pharmacist about the current price and availability, as prices can change. Do not use any other source as a substitute for what the pharmacy confirms.

How should Glims 3 mg Tablet be taken?

Your doctor decides the dose, how often and for how long you take it, based on your blood and urine glucose checks. Follow those instructions exactly and do not adjust the dose yourself. Ask your doctor or pharmacist if anything is unclear.

What is Glims 3 mg Tablet used for and what kind of medicine is it?

It is a sulfonylurea tablet containing glimepiride. It is used with diet and exercise to lower blood glucose in adults with type II diabetes not controlled by diet and exercise alone, and sometimes with metformin. It is not for type I diabetes.

Who should avoid Glims 3 mg Tablet or ask a doctor first?

Do not use it in type I diabetes, diabetic ketoacidosis or diabetic coma, or if allergic to glimepiride, other sulfonylureas or sulfonamides. It is unsuitable in severe liver or kidney problems and dialysis. It must not be used in pregnancy or breastfeeding. Ask your doctor if you take other medicines or have other health problems.

Indications

Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • ... Read more
Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
  • Combined use of Glimepiride and insulin may increase the potential for hypoglycaemia.

Pharmacology

Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.

Dosage & Administration

In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.

Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.

Dose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.

Distribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Normally, a single daily dose is sufficient. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. It is very important not to skip meals after taking the drug.

Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases; therefore, Glimepiride requirement may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. A dose adjustment must also be considered whenever the patient's weight or life-styie changes, or other factors arise which cause an increased susceptibility to hypo or hyperglycaemia.

Changeover from other oral antidiabetics to Glimepiride: There is no exact dosage relationship between Glimepiride and other oral blood sugar lowering agents. When substituting Glimepiride for other such agents, the initial daily dose is 1 mg; this applies even in changeover from maximum dose of other oral blood sugar lowering agents. Any dose increase should be in accordance with guideline given above in 'initial dose and dose titration'. Consideration must be given to the potency and duration of action of the previous blood sugar lowering agent. It may be necessary to interrupt treatment to avoid additive effects which would increase the risk of hypoglycaemia.

Interaction

Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.

In addition to insulin and other oral antidiabetic agents, drugs which may potentiate the hypoglycaemic action of Glimepiride include: ACE inhibitors, aminosalicylic acid, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (high dose parenteral), oxyphenbutazone, para-aminosalicylic acid, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide antibiotics, tetracyclines, tritoqualine, trofosfamide.

Drugs which may attenuate the hypoglycaemic action of Glimepiride include:
  • Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, laxatives, nicotinic acid (high doses), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic agents, thyroid hormones.
  • H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.
  • Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may mask the warning symptoms of a hypoglycaemic attack.
  • Acute and chronic aicohol intake may either potentiate or attenuate the activity of Glimepiride in an unpredictable fashion.

Contraindications

Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.

Side Effects

Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.

Pregnancy & Lactation

Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.

Precautions & Warnings

in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).

Overdose Effects

Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of  concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.

Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.

Alternative brands of Glimepiride

Other brands with the same generic name, cheapest first.

See all 41 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.